tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Income Statement

Compare
88 Followers

Barinthus Biotherapeutics Income Statement

Last quarter (Q3 2024), Barinthus Biotherapeutics's total revenue was $14.97M, an increase of Infinity% from the same quarter last year. In Q3, Barinthus Biotherapeutics's net income was $-8.11M. See Barinthus Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 802.00K$ 44.70M$ 268.00K$ 4.82M$ 6.87M
Gross Profit
$ 802.00K$ 44.70M$ 268.00K$ 4.82M$ 6.87M
Operating Expenses
$ 84.72M$ 47.50M$ 41.49M$ 21.59M$ 32.30M
Depreciation and Amortization
$ 5.45M$ 5.54M$ 601.93K$ 210.02K$ 346.86K
EBITDA
$ -71.06M$ 6.40M$ -47.86M$ -14.14M$ -22.31M
Operating Income
$ -83.91M$ -4.04M$ -45.22M$ -20.05M$ -25.77M
Other Income/Expenses
$ 7.39M$ 4.89M$ -5.92M$ 2.21M$ 2.98M
Pretax Income
$ -76.52M$ 850.00K$ -51.14M$ -17.84M$ -22.79M
Net Income
$ -73.35M$ 5.34M$ -50.87M$ -17.71M$ -20.82M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.91$ 0.14$ -1.37$ -371.62$ 0.00
Diluted EPS
$ -1.91$ 0.14$ -1.37$ -371.62$ 0.00
Weighted Average Shares Outstanding
38.39M 37.25M 37.19M 47.65K 0.00
Weighted Average Shares Outstanding (Diluted)
38.39M 38.17M 37.19M 47.65K 0.00
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis